Annamaria Romoli

Annamaria Romoli


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
ESEmilia Salvadori
Emilia Salvadori
GPGioele Papi
Gioele Papi
GIGreta Insalata
Greta Insalata
VRValentina Rinnoci
Valentina Rinnoci
IDIda Donnini
Ida Donnini
APAnna Poggesi
Anna Poggesi
Comparison studies on recovery outcomes in ischemic (IS) and hemorrhagic strokes (HS) have yielded mixed results. In this retrospective observational study of consecutive IS and HS patients, we aimed at evaluating functional outcomes at discharge from an intensive rehabilitation hospital, comparing IS vs. HS, analyzing possible predictors. Modified Rankin Scale (mRS) at discharge was the main outcome. Out of the 229 patients included (mean age 72.9 ± 13.9 years, 48% males), 81 had HS (35%). Compared with IS (n = 148), HS patients were significantly younger (75 ± 12.5 vs. 68.8 ± 15.4 years, p = 0.002), required longer hospitalizations both in acute (23.9 ± 36.7 vs. 35.2 ± 29.9 days, p = 0.019) and rehabilitation hospitals (41.5 ± 31.8 vs. 77.2 ± 51.6 days, p = 0.001), and had more severe initial clinical deficit (mean number of neurological impairments: 2.0 ± 1.1 vs. 2.6 ± 1.4, p = 0.001) and mRS scores at admission (p = 0.046). At discharge, functional status change, expressed as mRS, was not significantly different between IS and HS (F = 0.01, p = 0.902), nor was the discharge destination (p = 0.428). Age and clinical severity were predictors of functional outcome in both stroke types. On admission in an intensive rehabilitation hospital, HS patients presented a worse functional and clinical status compared to IS. Despite this initial gap, the two stroke types showed an overlapped trajectory of functional recovery, with age and initial stroke severity as the main prognostic factors.

15 July 2021 in Journal of Neurotrauma
Verified
Journal Article
Closed access
LLLucia Francesca Lucca
Lucia Francesca Lucca
ATAntonio De Tanti
Antonio De Tanti
FCFrancesca Cava
Francesca Cava
ARAnnamaria Romoli
Annamaria Romoli
RFRita Formisano
Rita Formisano
ACAntonio Cerasa
Antonio Cerasa
In this multicenter study, we provide a systematic evaluation of the clinical variability associated with paroxysmal sympathetic hyperactivity (PSH) in patients with acquired brain injury (ABI) to determine how these signs can impact outcomes. A total of 156 ABI patients with a disorder of consciousness (DoOC) were admitted to neurorehabilitation subacute units (IRU) and evaluated at baseline (T0), after 4 months from event (T1) and at discharge (T2). The outcome measure was the Glasgow outcome scale–extended, while age, sex, etiology, Coma Recovery Scale-revised (CRS-r), Rancho Los Amigos Scale (RLAS), early rehabilitation Barthel index (ERBI), PSH-assessment measure (PSH-AM) scores and other clinical features were considered as predictive factors. A machine learning (ML) approach was used to identify the best predictive model of clinical outcomes. The etiology was predominantly vascular (50.8%), followed by traumatic (36.2%). At admission, the prevalence of PSH was 31.3%, which decreased to 16.6% and 4.4% at T1 and T2, respectively. At T2, 2.8% were dead, 61.1% had a full recovery of consciousness, whereas 36.1% remained in VS or MCS. A Support Vector Machine (SVM) SVM-based ML approach provides the best model with 82% accuracy in predicting outcomes. Analysis of variable importance shows that the most important clinical factors influencing the outcome are the PSH-AM scores measured at T0 and T1, together with neurological diagnosis, CRS-r and RLAS scores measured at T0. This joint multicenter effort provides a comprehensive picture of the clinical impact of the PSH signs in ABI patients, demonstrating its predictive value in comparison with other well-known clinical measurements.

18 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RFRita Formisano
Rita Formisano
MAMarta Aloisi
Marta Aloisi
GFGiulia Ferri
Giulia Ferri
SSSara Schiattone
Sara Schiattone
AMAlfonso Magliacano
Alfonso Magliacano
Marco IosaMarco Iosa
Marco Iosa
Background/Objectives: Persons with disorders of consciousness (DoCs) may perceive pain without being able to communicate their discomfort. The Nociception Coma Scale (NCS) and its revised form (NCS-R) have been proposed to assess nociception in persons with DoCs. The main aim of this international multicenter study was to confirm (or not) our preliminary results and compare the NCS-R scores of standard stimulus (NCS-R-SS) to scores of personalized painful stimuli (NCS-R-PS). A secondary aim of the study was to verify possible correlations between the NCS-R-PS and Coma Recovery Scale—Revised (CRS-R) and to estimate convergent validity. Methods: Sixty-one patients with prolonged DoCs (pDoCs) were enrolled from seven European post-acute rehabilitation centers. Responsiveness and pain perception were assessed by CRS-R and NCS-R with standard stimulus (NCS-R-SS) and personalized stimulation (NCS-R-PS). ClinicalTrials.gov Identifier: NCT06012357. Results: our results support our prior findings on the superiority and the validity of the personalized painful stimulus approach in assessment of pain in persons with DoCs in comparison with the standardized pain assessment methodology. Conclusions: A more in-depth and tailored assessment of pain perception in persons with a DoC may lead to better acknowledgment of its presence and by extension an objective foundation for more aggressive and appropriate pain management.